Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0500
+0.0800 (4.06%)
NASDAQ · Last Trade: Jan 1st, 1:20 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors